160 related articles for article (PubMed ID: 3156493)
21. The specificity of human N-acetyl-beta-D-hexosaminidases towards glycosphincolipids is determined by an activator protein.
Conzelmann E; Sandhoff K
Adv Exp Med Biol; 1980; 125():295-306. PubMed ID: 6444774
[TBL] [Abstract][Full Text] [Related]
22. The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A.
Meier EM; Schwarzmann G; Fürst W; Sandhoff K
J Biol Chem; 1991 Jan; 266(3):1879-87. PubMed ID: 1824846
[TBL] [Abstract][Full Text] [Related]
23. Prenatal diagnosis of Tay-Sachs disease. Reflectometry of hexosaminidase A, B, and C/S bands on zymograms.
Kustermann-Kuhn B; Harzer K
Hum Genet; 1983; 65(2):172-5. PubMed ID: 6228513
[TBL] [Abstract][Full Text] [Related]
24. Hexosaminidase A deficient adults: presence of alpha chain precursor in cultured skin fibroblasts.
Frisch A; Baram D; Navon R
Biochem Biophys Res Commun; 1984 Feb; 119(1):101-7. PubMed ID: 6231027
[TBL] [Abstract][Full Text] [Related]
25. beta-hexosaminidase in cultured normal and mutant human fibroblasts: an immunohistochemical and biochemical investigation.
Elsafi ME; Elbashir MI; Hultberg B; Isaksson A; Hägerstrand I; Stenram U
Scand J Clin Lab Invest; 1991 Dec; 51(8):711-4. PubMed ID: 1839650
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
Poulos A; Holding J; Carey WF
Clin Chim Acta; 1982 Apr; 120(3):331-40. PubMed ID: 6210469
[TBL] [Abstract][Full Text] [Related]
27. Identification of candidate active site residues in lysosomal beta-hexosaminidase A.
Fernandes MJ; Yew S; Leclerc D; Henrissat B; Vorgias CE; Gravel RA; Hechtman P; Kaplan F
J Biol Chem; 1997 Jan; 272(2):814-20. PubMed ID: 8995368
[TBL] [Abstract][Full Text] [Related]
28. The biochemistry of HEXA and HEXB gene mutations causing GM2 gangliosidosis.
Mahuran DJ
Biochim Biophys Acta; 1991 Feb; 1096(2):87-94. PubMed ID: 1825792
[No Abstract] [Full Text] [Related]
29. Adult-onset GM2 gangliosidosis diagnosed in a fetus.
Navon R; Sandbank U; Frisch A; Baram D; Adam A
Prenat Diagn; 1986; 6(3):169-76. PubMed ID: 2941730
[TBL] [Abstract][Full Text] [Related]
30. Thermodynamic determination of plasma and leukocyte beta-hexosaminidase isoenzymes in homozygote and heterozygote carriers for the GM2 gangliosidosis B1 variant.
Casal JA; Pérez LF; Tutor JC
Am J Clin Pathol; 2003 May; 119(5):684-8. PubMed ID: 12760286
[TBL] [Abstract][Full Text] [Related]
31. Genetic complementation in somatic cell hybrids of four variants of infantile GM2 gangliosidosis.
Sonderfeld S; Brendler S; Sandhoff K; Galjaard H; Hoogeveen AT
Hum Genet; 1985; 71(3):196-200. PubMed ID: 2933318
[TBL] [Abstract][Full Text] [Related]
32. Unusual thermolability properties of leukocyte beta-hexosaminidase: implications in screening for carriers of Tay-Sachs disease.
Prence EM; Natowicz MR; Zalewski I
Clin Chem; 1993 Sep; 39(9):1811-4. PubMed ID: 8375052
[TBL] [Abstract][Full Text] [Related]
33. Thermal activation of hexosaminidase A in a genetic compound with Tay-Sachs disease.
Ben-Yoseph Y; Baylerian MS; Momoi T; Nadler HL
J Inherit Metab Dis; 1983; 6(3):95-100. PubMed ID: 6230486
[TBL] [Abstract][Full Text] [Related]
34. Alpha-locus hexosaminidase genetic compound with juvenile gangliosidosis phenotype: clinical, genetic, and biochemical studies.
Johnson WG; Cohen CS; Miranda AF; Waran SP; Chutorian AM
Am J Hum Genet; 1980 Jul; 32(4):508-18. PubMed ID: 6772023
[TBL] [Abstract][Full Text] [Related]
35. The biochemical genetics of the hexosaminidase system in man.
Beutler E
Am J Hum Genet; 1979 Mar; 31(2):95-105. PubMed ID: 377957
[TBL] [Abstract][Full Text] [Related]
36. Biochemical and molecular characterization of mutant hexosaminidase A in a Turkish family.
Sinici I; Ozkara HA; Topçu M; Ciliv G
Pediatr Int; 2003 Feb; 45(1):16-22. PubMed ID: 12654063
[TBL] [Abstract][Full Text] [Related]
37. A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside.
Sharma R; Bukovac S; Callahan J; Mahuran D
Biochim Biophys Acta; 2003 Jan; 1637(1):113-8. PubMed ID: 12527415
[TBL] [Abstract][Full Text] [Related]
38. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J
Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632
[TBL] [Abstract][Full Text] [Related]
39. N-acetyl-beta-hexosaminidase B deficiency in cultured fibroblasts from a patient with progressive motor neuron disease.
Hancock LW; Horwitz AL; Cashman NR; Antel JP; Dawson G
Biochem Biophys Res Commun; 1985 Aug; 130(3):1185-92. PubMed ID: 3161509
[TBL] [Abstract][Full Text] [Related]
40. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
